Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07049991

Para-Prosthetic Valve Leak Closure Observatory - PVLC2

Para-prosthetic heart valve leakage is an evolving complication after surgical or percutaneous heart valve replacement. These leaks can lead to heart failure and/or life-threatening hemolysis.

Percutaneous closure of para-prosthetic leaks has developed as an alternative to surgery in high-risk surgical patients. These procedures remain difficult on the technical side with a significant risk of failure and complications but have been improving since the development of dedicated prostheses and the increase in operator experience.

A sharing of experience through the creation of an international expert group has been initiated since 2017 formalised by biannual expert meetings, the elaboration of recommendations in progress and the establishment of an international observatory PVLC1(CCTIRS N°16-62) on 2017-2019.

Beyond the technical aspects and the follow-up of major cardiovascular events collected in PVLC1, the investigators also wonder what impact these procedures have on the quality of life of patients. The investigators suggest that even a partial decrease in para-prosthetic leakage may be associated with an improvement in quality of life by reducing the need for transfusion and/or reducing dyspnea.

A new PVLC2 study is justified to continue the evolutionary follow-up of the technical and clinical results of these procedures, accompanied by the evaluation of the possible benefit on the quality of life of the patients.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Marie Lannelongue Hospital

Le Plessis-Robinson, 92350, France

Location status: Recruiting

Location contact

Sebastien HASCOËT, MD

CONTACT

[email protected]

01.40.94.24.29

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 16 years and older
  • Non-opposition of the patient or child's legal representative
  • Patient referred for a percutaneous para-prosthetic leakage closure procedure

Exclusion criteria

  • ≤ 16 years of age
  • Refusal of the patient to participate in the observatory or the legal representative if the patient is a minor.

Treatment and study plan

surgical or percutaneous heart valve replacement.

Procedure

para-prosthetic heart valve leakage after after surgical or percutaneous heart valve replacement

Primary outcomes

  1. Evaluate the technical and clinical results of the closure of para-prosthetic leaks by assessing the clinical success of the procedure

    Time frame: 2 years

    Clinical success of the procedure

Sponsors and collaborators

Lead sponsor

Fondation Hôpital Saint-Joseph

Other

Registry information

Acronym: FFPP2

Important dates

Study start
2020
Primary completion
2022
Study completion
2027
First posted
Jul 3, 2025
Registry last updated
Jul 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.